Justices seem skeptical about arguments to limit access to abortion drug mifepristone

Mifepristone is one of the most common pills to end a pregnancy. 
Pro-abortion rights activists demonstrate in front of the U.S. Supreme Court Building on June 13, 2022 in Washington, DC.

Supreme Court justices seem to show concern Tuesday about arguments before them to limit access to the abortion drug mifepristone due to how the FDA changed its availability over the past decade, according to news reports.

The Associated Press reported that remarks from the justices indicate they may not touch the current rules that allow mifepristone to be delivered through the mail without a visit to the doctor.

Abortion opponents are requesting the high court limit access to the drug.

Solicitor General Elizabeth Prelogar argued that access to the drug is a right and the Food and Drug Administration had the right to relax the rules on accessing it, the wire service also reports. 

The Supreme Court likely won't rule to limit access to the pill and seemed skeptical of the arguments from abortion opponents, The Washington Post. Mifepristone is one of the two most common pills to end a pregnancy.